BFRI
Biofrontera Inc
NASDAQ: BFRI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.08
-1.82% today
Updated 2026-04-30
Market cap
$12.58M
P/E ratio
—
P/S ratio
0.30x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Biofrontera Inc (BFRI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-25.30%
Operating margin
26.70%
ROE
-141.30%
ROA
-28.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $26.18M | $-10.98M | 52.61% | -57.00% | -41.95% |
| 2020 | $18.85M | $-10.99M | 51.90% | -50.96% | -58.29% |
| 2021 | $24.10M | $-37.71M | 47.13% | -104.57% | -156.49% |
| 2022 | $28.67M | $-640000.00 | 47.04% | -64.80% | -2.23% |
| 2023 | $34.07M | $-20.13M | 48.80% | -66.56% | -59.09% |
| 2024 | $37.30M | $-17.76M | 50.12% | -46.14% | -47.61% |
| 2025 | $41.70M | $-10.54M | 75.76% | -27.21% | -25.26% |